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a  b  s  t  r  a  c  t
Dengue is a major worldwide public health problem, especially in the tropical and subtropi-
cal  regions of the world. Primary infection with a single Dengue virus serotype causes a mild,
self-limiting febrile illness called dengue fever. However, a subset of patients who experi-
ence  secondary infection with a different serotype can progress to a more  severe form of the
disease, called dengue hemorrhagic fever. The four Dengue virus serotypes (1–4) are antigeni-
cally  and genetically distinct and each serotype is composed of multiple genotypes. In this
study we isolated one Dengue virus 1 serotype, named BR/Alfenas/2012, from a patient with
dengue hemorrhagic fever in Alfenas, South Minas Gerais, Brazil and molecular identiﬁca-
tion  was performed based on the analysis of NS5 gene. Swiss mice were infected with this
isolate to verify its potential to induce histopathological alterations characteristic of dengue.
Liver histopathological analysis of infected animals showed the presence of inﬂammatory
inﬁltrates, hepatic steatosis, as well as edema, hemorrhage and necrosis focal points. Phy-
logenetic and evolutionary analyses based on the envelope gene provided evidence that the
isolate BR/Alfenas/2012 belongs to genotype V, lineage I and it is probably derived from iso-lates  of Rio de Janeiro, Brazil. The isolate BR/Alfenas/2012 showed two unique amino acids
substitutions (SER222THRE and PHE306SER) when compared to other Brazilian isolates from
neage. Molecular models were generated for the envelope protein indi-the  same genotype/licating that the amino acid alteration PHE 306 SER could contribute to a different folding in
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this region located within the domain III. Further genetic and animal model studies using
BR/Alfenas/2012 and other isolates belonging to the same lineage/genotype could help
determine the relation of these genetic alterations and dengue hemorrhagic fever in a
susceptible population.
© 2015 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda. This is
an open access article under the CC BY-NC-ND license
for phylogenetic and evolutionary analyses since it is a moreIntroduction
Dengue virus (DENV) is an arbovirus transmitted to humans
through the bite of infected Aedes aegypti mosquitoes. Dengue
disease is endemic in several countries of Africa, the Amer-
icas, Mediterranean, Southeast Asia and the Western Paciﬁc
and almost half of the world’s population live in risk areas
for dengue.1 DENV infects 50–100 million people each year
and among the infected patients 500,000 are at risk to develop
the more  severe diseases, such as Dengue Hemorrhagic Fever
(DHF).2,3 DENV is an enveloped virus that belongs to the fam-
ily Flaviviridae, genus Flavivirus.  The viral genome encodes a
single open reading frame which, when translated, produces
a polyprotein that is processed into three structural proteins
(capsid, membrane and envelope proteins) and seven non-
structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, NS5).
The phylogenetic analysis of DENV isolates provides
insights into the evolutionary and the migratory processes of
DENV, thus contributing to a better understanding of the epi-
demiology of the disease.4–6 In Brazil, the circulation of all four
DENV serotypes has been reported and several studies have
revealed a substantial genetic diversity among Brazilian DENV
serotypes/genotypes. One DENV-1 outbreak was reported in
Northern region of Brazil, in 1981, but it only established wider
circulation in the country a few years later. DENV-1 was prob-
ably reintroduced into Brazil in 1984–19857 and in 1986 an
outbreak was reported in the Southeast region. Subsequently,
DENV-1 spread throughout the country. In the following years,
the other 3 serotypes (DENV-2, DENV-3 and DENV-4) were
also introduced into Brazil.8–10 The phylogenetic studies of
Brazilian DENV-1 isolates revealed the circulation of different
lineages of genotype V7,11,12 introduced into the country in
different times, probably from different countries, leading to
lineage replacement or to the co-circulation of different DENV-
1 lineages.7
The Minas Gerais State (Southeast region of Brazil) has been
gone through recurrent epidemics of dengue. DENV was ﬁrst
described in Minas Gerais in 1987, and since 1996, regular
outbreaks have caused considerable illness in the state. Dur-
ing 1987–2010 the viral isolation data showed the presence of
DENV-1, DENV-2, and DENV-3 in Minas Gerais and only in 2011
was DENV-4 reported in the state. Beside the circulation of all
4 serotypes in the Minas Gerais State, DENV-1 continued to
be the most frequent serotype observed in 2011 and 2012.13
Despite the importance of the disease for the region, there
have not been many  studies that analyze the genetic variabil-
ity of DENV isolates in this region. Therefore, this work aims
to perform a molecular and phylogenetic analysis of a DENV-1
strain isolated in southern Minas Gerais state, Brazil.(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Material  and  methods
Strain  and  sample  preparation
The strain BR/Alfenas/2012 was obtained from a serum sam-
ple derived from a patient with dengue hemorragic fever,
in 2012, in Alfenas, Minas Gerais State, Brazil. The patient
presented skin hemorragic manifestations and laboratory
ﬁndings demonstrated the increase in hematocrit concur-
rent with rapid decrease in platelet count. Serological tests
conﬁrmed the presence of anti-Dengue IgM and IgG (Pan-
bio Dengue Duo IgM and IgG Capture ELISA, Alere, Australia)
conﬁrming thus, the secondary infection of this patient.
Blood was collected seven days after the onset of the ﬁrst
symptoms upon authorization of the patient. This study
was carried out by following the rules and laws  that govern
the use of human and animal material (approved protocol
08410912.9.0000.5142).
Cells  and  virus  isolation
Aedes albopictus C6/36 cells were propagated in Leibovitz L15
medium (Cultilab, Brazil) supplemented with 10% fetal calf
serum (Cultilab, Brazil) at 28 ◦C and then used for virus iso-
lation. For virus isolation, a 50-L sample of serum was
incubated with C6/36 cells supplemented with 2% fetal
calf serum. Infected C6/36 cells showing typical cytopathic
effect were harvested, and the tissue culture supernatants
were used for viral RNA extraction QiAmp Viral RNA kit
(QIAGEN, USA). Uninfected cells were used as negative
controls.
RT-PCR  and  sequencing  of  NS5  and  Envelope  gene
First reverse transcription and ampliﬁcation was performed
using universal primers targeting all three ﬂavivirus sub-
groups as previously described.14 The region ampliﬁed
encoded part of the methyltransferase and most of the RNA-
dependent-RNA-polymerase domain of NS5 and, given its
conserved pattern, it was chosen for ﬂavivirus detection and
identiﬁcation. Second, a reverse transcription and ampliﬁ-
cation of the full envelope gene was performed using the
protocol previously described.7 The envelope gene was chosenvariable gene that possesses a robust phylogenetic signal. All
amplicons were sequenced using the Big Dye chemistry (USA)
on ABI3730xl DNA sequencers according to Applied Biosys-
tems protocols.
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hylogenetic  and  evolutionary  analyses
he generated sequences were compared with sequences
eposited in GenBank using the BLASTN program
www.ncbi.nlm.nih.gov/blast).15 Nucleotide sequences from
nvelope (total of 118 sequences, spanning 1485 bp) and
S5 (total of 72 sequences of 789 bp) genes were retrieved
rom GenBank and used for phylogenetic and evolutionary
nalyses. Nucleotide sequences were aligned using Clustal W
rogram implemented in MEGA6.16 Using the software MEGA
, the nucleotide substitution model that best ﬁt the data
as chosen (Tamura-Nei (TN93 + G))17 and then it was used
o estimate the evolutionary distance between sequences.
hylogenetic trees were reconstructed based on envelope or
artial NS5 gene sequences, using the nucleotide substitution
odel TN93 + G, the Maximum Likelihood method, and 1000
ootstrap replicates.18,19
Coalescent trees were also reconstructed through Bayesian
nalysis and the time of the most recent common ancestor
MRCA) for some strains and lineages was calculated using
EAST package v.1.8. with Markov Chain Montecarlo algo-
ithms (MCMC).20 BEAUTI v.1.8.120 was used to create input
les for BEAST, using 119 DENV-1 envelope gene sequences
nd the year each strain was obtained was used as the cal-
bration point. Three different runs were performed using
he nucleotide substitution model TN9317 with four gamma
ategories, the Bayesian Skyline method,21 under relaxed
uncorrelated lognormal) molecular clock. One hundred mil-
ion chains were run (discarding the ﬁrst ten million steps)
nd data and trees were sampled every 5000 steps. The
esults from three independent runs were combined using
ogCombiner,22 resulting in 54,000 trees that were summa-
ized in a maximum clade credibility tree, using TreeAnotator
 1.8.1.23 The convergence of parameters was veriﬁed with the
racer v1.6.024 and uncertainties were addressed as the 95%
ighest probability density (HPD) intervals The ﬁnal tree was
isplayed in FigTree v1.4.2.25 For phylogeographic inferences,
nalyses were performed as described with the addition of a
eographic location attribute to each taxon and the analyses
ere carried out using a standard continuous-time Markov
hain (CTMC) and a Bayesian stochastic search variable selec-
ion (BSSVS).26
olecular  modeling  of  envelope  protein
olecular models were generated for the envelope protein
sing MODELLER 9.12 software and also using three DENV-1
nvelope proteins as templates (PDB codes: 4B03 (resolu-
ion 6 A), 4C2I (resolution 6 A) and 4GSX (resolution 1.90).27
lignment of target and template sequences was made using
he program clustalW2.28 We have generated 50 templates
or each molecule, using a slow level of molecular dynam-
cs and a variable target function method. The maximun
umber of interactions was equal to 500, with 2 cycles of
ptimization. The selected models were overlapped using
he VMD  program, giving prominence to the amino acid
esidues that differ between the proteins.29 The stereochem-
cal quality of the model was evaluated using PROCHECK
oftware.30o l o g y 4 7 (2 0 1 6) 251–258 253
Infection  of  mice  and  histopathological  analysis
Six weeks old mice were infected intraperitoneally with
1.0 × 104 plaque forming units (pfu) of DENV-1 (n = 5) and unin-
fected mice (n = 5) was used as negative control. After 7 days of
infection the animals were euthanised by cervical dislocation,
and the liver removed for histopathological studies. The route
of infection and time of histopathological analysis were stan-
dardized in previous studies (unpublished data). The livers
were ﬁxed with 10 % formaldehyde in PBS at room temper-
ature, dehydrated in ethanol and embedded in parafﬁn. Serial
sections (5 m)  were stained with hematoxylin and eosin. The
tissue slides were examined under a Carl Zeiss Axio Scope
A1 microscope attached to a Canon G10 Power Shot digital
microscope camera and the captured images were analyzed
with Remote Capture DC Software version 4.8. Sections were
analyzed to identify the histopathological changes described
in DENV infected mice.31–33
Results
DENV-1 was isolated from a serum specimen derived from a
patient with DHF, in Alfenas, in the South of Minas Gerais
State, Brazil. Microscopic examination of cells inoculated with
serum from the patient showed a typical cytopathic effect
(CPE) in the second passage and the CPE was more  intense
in the ﬁfth passage (data not show). Swiss mice were infected
with BR/Alfenas/2012 in order to identify the histopathologi-
cal alterations induced by the isolate. As showed in Fig. 1, the
liver of infected animals showed the presence of an inﬂamma-
tory inﬁltrate around the central veins and also focal points
of edema, hemorrhage and necrosis. We also observed the
presence of steatosis when compared to uninfected animals.
Cell supernatant from C6/36 cells infected with DENV-
1 BR/Alfenas/2012 (fourth passage) was collected and used
for total RNA extraction, RT-PCR reactions and nucleotide
sequencing. Sequences corresponding to DENV envelope
(GenBank KJ651912) and partial NS5 (GenBank KJ651911) were
used for phylogenetic analyses. Brazilian DENV-1 strains,
including DENV-1 BR/Alfenas/2012 were grouped within geno-
type V based on NS5 (data not shown) and E sequences
analyses (Fig. 2). Brazilian strains were subdivided into dif-
ferent lineages and DENV-1 BR/Alfenas/2012 was clustered
with DENV-1 strains from Venezuela and Brazil, detected from
1997 up to 2012. DENV-1 BR/Alfenas/2012 was closely related
to strains obtained in the states of Rio de Janeiro (Southeast
Brazil) and Pernambuco (Northeast Brazil).
Coalescent and phylogeographic analyses estimated that
DENV-1 BR/Alfenas/2012, DENV-1/1266/2011/BR/RJ and DENV-
1/0122 2011/BR/RJ shared the most recent common ancestor
(MRCA), dating from 2008 (3.65 years before 2012, 95%
HPD = 2.23–5.38) (Fig. 2), probably from Southeast Brazil (data
not shown). DENV-1 BR/Alfenas/2012 together with strains
from Rio de Janeiro and from Pernambuco shared the MRCA
dating at 2006 (5.12 years before 2012, 95% HPD = 3.58–7.11).
These Brazilian strains shared the MRCA with strain DENV-
1/VE/BID-V2468/2008 at 2005 (6.80 years before 2012, 95%
HPD = 4.93–9.40), from Venezuela (Fig. 2).
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Fig. 1 – Histopathological analysis of DENV-1 (BR/Alfenas/2012) infected animals. (A) and (B) Liver sections from uninfected
mice in increases of 400 and 1000×, respectively; (C)–(H) Liver sections of DENV-1 infected animals demonstrating the
presence of inﬂammatory inﬁltrate (C and D); focal points of hemorrhage, edema and necrosis (E and F) and hepatic
steatosis (G and H). Abbreviations: IF, inﬂammatory inﬁltrate; N, necrosis; He, hemorrhage.The evolutionary divergence estimate between DENV-1
BR/Alfenas/2012 and the Brazilian strains DENV-1/1266/
2011/BR/RJ, DENV-1/0122 2011/BR/RJ, DENV-1/15 2010/BR/RJ/
2010, DENV-1/148985/BR/PE/10, DENV-1/13501/BR-PE/10 and
DENV-1/12898/BR-PE-10 ranged from 1.20 ± 0.30 to 1.64 ± 0.36,based on envelope gene nucleotide sequences (Table 1).
When DENV-1 BR/Alfenas/2012 was compared to strains
from Venezuela, VE/BID-V2468/2008, VE/BID-V2254/2005,
VE/BID-V3540/1997 and VE/BID-V2261/2006, the genetic
distance ranged from 1.64 ± 0.36 to 2.50 ± 0.47 (Table 1).
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KJ651912/DENV-1/BR/ALFENAS/2012
MRCA = 2008
MRCA = 2006
MRCA = 2005
MRCA = 1992
*
*
*
*
*
*
*
*
*
*
*
*
**
*
* *
*
*
**
1882 1912 1962 2012
JN122281/DENV-1/BR/0122_2011/BR/RJ/2011
KF672760/DENV-1/BR/1266/2011/BR/RJ/2011
HQ696612/DENV-1/BR/15_2010/BR/RJ/2010
JX669466/DENV-1/BR/14985/BR-PE/10/2010
JX669462/DENV-1/BR/12898/BR-PE/10/2010
JX669463/DENV-1/BR/13501/BR-PE/10/2010
JF850103/DENV-1/VE/BID-V2468/2008
FJ639814/DENV-1/VE/BID-V2254/2005
GU056029/DENV-1/VE/BID-V3540/1997
FJ639821/DENV-1/VE/BID-V2261/2006
BR, CO, VE (2004-2008)
VE, CO (1998-2005)
VE, NI, MX (1998-2009)
JF937635/DENV-1/NI/BID-V5504/2009
GQ199859/DENV-1/NI/BID-V2652/2008
FJ639735/DENV-1/VE/BID-V2162/1997
GU131833/DENV-1/VE/BID-V3549/2000
FJ639741/DENV-1/VE/BID-V2169/1998
GU131835/DENV-1/VE/BID-V3552/2004
BR (1986-2002)
FJ410188/DENV-1/US/BID-V2139/1996
FJ205874/DENV-1/US/BID-V1743/1995
US_PR, ARG, PAR (1993-2000)
AF425613/DENV-1/BR/BEAR404147/1982
BR (2000-2010)
GQ868601/DENV-1/VG/BID-V2937/1985
DQ285559/DENV-1/Reunion_191/04/2004
EU081258/DENV-1/D1/SG/05K4147DK1/2005
AF298807/DENV-1/Abidjan/1998
AY713473/DENV-1/Myanmar_40553/71/1971
AY722801/DENV-1/D1_Myanmar_40568/76/1976
AY762084/DENV-1/Singapore_8114/93/1993
G1, G2, G3, G4
Fig. 2 – Phylogenetic analysis of DENV-1 strains. Bayesian coalescent analysis of DENV-1 strains was performed using a
total of 119 envelope protein coding sequence (1485 bp). The phylogeny and time of the most recent common ancestor
(MRCA) were  estimated using the year of isolation of each DENV-1 strain as the calibration point, under the relaxed
molecular clock, with the Tamura Nei Model, with discrete Gamma  distribution. The maximum clade credibility tree is
shown, summarizing data from three independent runs. Posterior probabilities with values ≥98 are represented by an
asterisk (*) and black circles in each node or branch represent the nucleotide substitution rate. The years that the some most
recent common ancestors (MRCA) were  estimated to exist are shown for some nodes. Sequences are initially identiﬁed by
their GenBank accession number. Brazilian strains or lineages containing Brazilian strains are shown in black. For clarity
purposes some branches were  collapsed as follows: [BR, CO, VE (2004–2008): FJ850093, FJ639820, FJ850100, FJ639818,
GQ868562, FJ639823, FJ882579, FJ639813, FJ639808, FJ639797, GQ868570, GQ868568, GU131949, GQ868569]; [BR (1986–2002):
JX669475, KF672764, FJ850073, KF672763, AY277665, JX669470, JX669471, JX669474, JX669473, JX669472, JX669468,
JX669467, AF311958, AF311957, JX669469, AF311956, KF672761, KF672762, AF226685, JN122280, HQ026760, AF425614]; [BR
(2000–2010): HM043709, HQ026762, HQ696614, HQ026761, JX669464, GU131863, KF672759, FJ850087, JX669461, JX669465,
FJ850081, FJ850075, FJ850070, FJ850090, FJ850084, FJ850077, FJ850071]; [VE, CO (1998–2005): GU131834, GU131948, FJ639743,
GQ868561, GU131837, FJ639740, GQ868560]; [VE, NI, MX  (1998–2009): JQ287666, FJ024479, FJ182002, GQ868530, FJ024485,
FJ547088, EU596501, FJ898437, FJ898433, GQ868499, FJ810419, GU131984, GQ868500, HQ166037, FJ024483, GU131957,
GU056032]; [US PR, ARG, PAR (1993–2000): AF514878, AY277666, AY277664, FJ390380, FJ410184, EU482567] and [G1, G2, G3,
G4: FJ196845, FJ196842, DQ285561, JF960217, EU863650, DQ672563, EU848545, EU081262]. BR: Brazil, VE: Venezuela, CO:
Colombia, NI: Nicaragua, MX:  Mexico, US PR: Porto Rico, ARG: Argentina, PAR: Paraguay, G1, G2, G3, G4: genotypes 1, 2, 3
and 4, respectively. Analysis was carried out using BEAST package v.1.8.1, BEAUTi v.1.8.1, Tracer v.1.6.0, TreeAnotator v.1.8.1
a
S
B
w
V
B
Dnd FigTree v.1.4.2 and LogCombiner v1.8.1.
urveying the nucleotide alignment, we  observed that DENV-1
R/Alfenas/2012 presents 15 unique nucleotide substitutions
hen compared to the closest strains from Brazil and
enezuela (DENV-1/1266/2011/BR/RJ, DENV-1/0122 2011/
R/RJ, DENV-1/15 2010/BR/RJ/2010, DENV-1/148985/BR/PE/10,
ENV-1/13501/BR-PE/10 and DENV-1/12898/BR-PE-10, VE/BID-V2468/2008, VE/BID-V2254/2005, VE/BID-V3540/1997 and
VE/BID-V2261/2006).DENV-1 BR/Alfenas/2012 presented a conservative aa sub-
stitution (ARG 394 LYS), in position 394 of the deduced amino
acid envelope protein sequence (domain III). This conserva-
tive aa substitution was also observed for other sequences,
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Table 1 – Estimates of evolutionary divergence between DENV-1 envelope gene sequences.
[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11]
[1] BR/ALFENAS/2012 0.30 0.31 0.35 0.34 0.35 0.36 0.36 0.35 0.39 0.47
[2] 1266/2011/BR/RJ/2011 1.20 0.12 0.15 0.16 0.14 0.16 0.20 0.21 0.24 0.33
[3] 0122 2011/BR/RJ/2011 1.27 0.20 0.20 0.19 0.19 0.20 0.24 0.25 0.28 0.37
[4] 15 2010/BR/RJ/2010 1.47 0.34 0.55 0.15 0.14 0.15 0.18 0.19 0.22 0.31
[5] 14985/BR-PE/10/2010 1.64 0.41 0.62 0.34 0.12 0.14 0.19 0.18 0.22 0.30
[6] 13501/BR-PE/10/2010 1.57 0.34 0.55 0.27 0.20 0.12 0.18 0.17 0.22 0.30
[7] 12898/BR-PE/10/2010 1.64 0.41 0.62 0.34 0.27 0.20 0.20 0.19 0.23 0.31
[8] VE/BID-V2468/2008 1.64 0.55 0.76 0.48 0.55 0.48 0.55 0.13 0.22 0.28
[9] VE/BID-V2254/2005 1.65 0.56 0.77 0.48 0.55 0.48 0.55 0.27 0.15 0.23
[10] VE/BID-V3540/1997 1.88 0.77 0.99 0.69 0.76 0.69 0.76 0.62 0.34 0.27
[11] VE/BID-V2261/2006 2.50 1.35 1.57 1.27 1.34 1.27 1.34 1.05 0.76 0.97
The number of base substitutions per site between sequences are shown. Standard error estimates are shown above the diagonal in bold and
italic.
Lys307
Lys325
Lys325
0
N
C
CA
CB
0G
Lys307
Ser305
Ser305
Tyr326Gly381
Ile335
Ser306
Phe306
Val380
Val324
Val324
Fig. 3 – Hydrophobic interactions between the residue PHE306 of the isolate 0122 2011/BR/RJ/2011 and neighboring amino
utateacids (left) compared to the equivalent interactions of the m
but some strains (DENV-1/BR/1266/2011/BR/RJ/2011, DENV-
1/BR/0122 2011/BR/RJ/2011, DENV-1/BR/15 2010/BR/RJ/2010,
DENV-1/BR/14985/BR-PE/10/2010, DENV-1/BR/13501/BR-
PE/10/2010, DENV-1/BR/12898/BR-PE/10/2010,
VE/BID-V2468/2008, VE/BID-V2254/2005, VE/BID-V3540/1997
and VE/BID-V2261/2006) possessed an arginine residue.
Moreover, DENV-1 BR/Alfenas/2012 possessed two unique
amino acid substitutions, at positions 222 (domain II) and 306
(domain III), when compared to other Brazilian isolates. At
position 222, one conservative amino acid substitution (SER
222 THR) was observed in DENV-1 BR/Alfenas/2012 sequence
where threonine was observed. One non-conservative aa
substitution took place at position 306 (PHE 306 SER) where
DENV-1 BR/Alfenas/2012 exhibited a serine residue. In a
second search in GenBank, looking for sequences that might
also possess the same amino acid residue in this position,
it was observed that one DENV-1 isolated from Viet Nam
(D1.QuyNhon.29.06 – KC861922), obtained in 2006, also had
the same amino acid residue in this position.
The molecular model of E protein from isolate
BR/Alfenas/2012 in superposition with the isolate DENV-
1/BR/0122 2011/BR/RJ/2011 showed a highly similar three
dimensional model (data not showed). The aa substitutions
SER 222 THR and ARG 394 LYS does not affect the predictedd residue SER306 in the isolate BR/Alfenas/2012 (right).
protein structure, since these are conservative substitutions
between amino acids with very similar characteristics (Fig. 3).
The other mutation (PHE 306 SER) would likely have a more
pronounced effect in the predicted protein structure. The
change of PHE by SER could decreases the interaction with
several other residues (SER305, LYS307, LYS325, VAL380,
VAL324, ILE335, TYR326 e GLY381) of envelope protein which
can contribute to a different folding in this region (Fig. 3).
Discussion
In 2012, a serum sample from a suspected dengue patient
with hemorrhagic manifestations was sent to our laboratory
in Unifal-MG. Laboratory tests and the clinical manifesta-
tions classiﬁed this patient as having grade II DHF. After viral
isolation, the ampliﬁcation, sequencing and analysis of NS5
gene (partial sequence) conﬁrmed that BR/Alfenas/2012 was
a DENV-1 isolate. Previous studies have demonstrated that
4,7,11,12genotype V is the only DENV-1 genotype in Brazil with
different lineages circulating in the country.7,11,12 The same
pattern was observed after our phylogenetic analyses based
on the envelope gene where Brazilian DENV-1 strains were
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rouped into different lineages from genotype V, including
R/Alfenas/2012, which was also grouped within lineage I.7
DENV-1/BR/Alfenas/2012 presented a close relationship
ith strains from Brazil and Venezuela, sharing the MRCA
ith Venezuelan strains dating at 1994, conﬁrming previ-
us estimations.7 The Venezuelan strain that was closest
o Brazilian strains was VE/BID-V3468/2008, which shared
he MRCA  with Brazilian strains at 2005, also as previously
stimated.7 Within that lineage, DENV-1 BR/Alfenas/2012 was
ost closely related to strains from Rio de Janeiro, a neighbor
tate in Southeast Brazil. The results indicated that DENV-1
R/Alfenas/2012 is derived from strains circulating in South-
ast Brazil, most probably from Rio de Janeiro, based on the
vailable information. The MRCA  of DENV-1 BR/Alfenas/2012
nd two  strains from Rio de Janeiro dated from 2008, indicat-
ng that the former strain might have been introduced into the
outhern region of Minas Gerais state, a few years before this
train was isolated from a patient with DHF, in 2012.
The evolutionary distance between DENV-1
R/Alfenas/2012 and closely related strains (as shown in
able 1 and Fig. 2) indicated that this strain had a local
volution, resulting in a more  genetically divergent strain.
his is supported by the higher nucleotide substitution rate
f this strain when compared to other DENV-1 strains and by
he 15 unique nucleotide substitutions observed in DENV-1
R/Alfenas/2012 envelope gene sequence (supplementary
ata) and three amino acid substitutions observed in the
educed amino acid envelope protein sequence.
Alignment of the deduced aa sequences for the envelope
rotein of the isolated BR/Alfenas/2012 with the other isolates
ndicates the presence of two unique amino acids substitut-
ons that were described for the ﬁrst time in Brazil. Many
tudies have shown that mutations that affect the E protein
ay alter the virulence of DENV, because these mutations may
odify the viral particle interaction with surface receptors
n the host cell or even interfere with the DENV fusion pro-
ess with the host cell membrane.34–37 The ﬁrst amino acid
ubstitution was observed in the residue 222 and this substi-
ution was also described in DENV-1 isolated in Philippines
South Paciﬁc), which belonged to genotype IV and ﬁxed in all
solates of DENV-1 obtained in this country since 2002. The
esidue 222 is localized in domain II, which is implicated in
he dimerization of the envelope protein at acidic pH preced-
ng the membrane fusion and viral entrance into the host cell.
owever, the authors did not ﬁnd any relationship with clin-
cal severity of human infection and so they suggested that
ER 222 THR is not a virulence determinant.
The other amino acid substitution was observed in the
esidue 306 and it is located in the domain III of protein
. This domain is involved in receptor binding with the
xposed residues on the surface of the virus, being respon-
ible for determining receptor speciﬁcity, vector type and
ost and tropism of cells.38–40 The segment located between
esidues 298 and 397 have been shown to be the target of a
umber of neutralizing antibodies, and aa substitutions in
his region could be related with a escape of neutralizing
41ntibodies. The presence of this aa substitution and the dif-
erences observed in the molecular model could strengthen
he role of this substitution to potentially escape neutralizing
ntibodies.o l o g y 4 7 (2 0 1 6) 251–258 257
It is known that the introduction of new serotypes and/or
genotypes/lineages of DENV is an important risk factor for
dengue fever outbreaks. Susceptibility of a population to a spe-
ciﬁc serotype and the occurrence of secondary infections in a
hyperendemic country have also very important role to under-
standing the epidemiology of the disease. Different DENV
serotypes, genotypes and even lineages can be introduced into
new areas increasing the genetic diversity of viral population.
In addition, clonal evolution has been assumed to be most
important factor in DENV evolution.6 In this scenario, moni-
toring the DENV is of great importance to observe the spread of
potentially virulent isolates, as well as to assess their evolution
and impact on the population during an outbreak/epidemic.
This is the ﬁrst report of DENV-1 isolation and char-
acterization in the southern region of Minas Gerais state,
Brazil, associated with DHF. BR/Alfenas/2012 was isolated
from a patient with DHF, during a secondary DENV infec-
tion and phylogenetic and molecular analyses indicated
that this virus belongs to a lineage of DENV-1, geno-
type V, recently introduced into the country, probably from
Venezuela. BR/Alfenas/2012 is most probably originated from
Rio de Janeiro, but after its introduction in a new region,
this strain underwent local evolution, exhibiting a higher
nucleotide substitution rate, leading to this more  genetically
divergent strain. However, additional studies should be done
to determinate the relationship of these genetic alterations in
terms of having the increased potential to induce DHF in a
susceptible population.
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